Table 4.
Univariate and multivariate survival analyses of clinicopathologic factors, GPER and Ezrin expression.
| Univariate model | Multivariate model | ||||||
|---|---|---|---|---|---|---|---|
| P* | OR | 95% CI for OR | P** | HR | β | 95% CI for HR | |
| Any event | |||||||
| Age | 0.836 | 0.997 | 0.974–1.022 | ||||
| Site (left vs right) | 0.527 | 1.182 | 0.704–1.986 | ||||
| Nuclear grade (G2 vs G3) | 0.001 | 0.203 | 0.083–0.500 | 0.001 | 0.240 | −1.425 | 0.104–0.566 |
| Tumor size | 0.088 | 1.146 | 0.980–1.340 | ||||
| LNM (no vs yes) | <0.001 | 0.369 | 0.216–0.629 | 0.072 | 0.621 | −0.476 | 0.370–1.043 |
| TNM (I/II vs III) | <0.001 | 0.187 | 0.101–0.345 | 0.002 | 0.436 | −0.831 | 0.257–0.740 |
| GPER (low vs high) | <0.001 | 0.173 | 0.096–0.313 | <0.001 | 0.393 | −0.933 | 0.246–0.629 |
| Ezrin (low vs high) | <0.001 | 0.274 | 0.156–0.479 | 0.141 | 0.697 | −0.361 | 0.431–1.127 |
| Death | |||||||
| Age | 0.489 | 1.009 | 0.983–1.036 | ||||
| Site (left vs right) | 0.634 | 0.871 | 0.493–1.538 | ||||
| Nuclear grade (G2 vs G3) | 0.002 | 0.153 | 0.046–0.511 | 0.007 | 0.201 | −1.606 | 0.063–0.644 |
| Tumor size | 0.021 | 1.215 | 1.030–1.434 | 0.023 | 1.168 | 0.156 | 1.022–1.336 |
| LNM (no vs yes) | <0.001 | 0.218 | 0.118–0.402 | 0.064 | 0.533 | −0.629 | 0.274–1.036 |
| TNM (I/II vs III) | <0.001 | 0.119 | 0.063–0.228 | 0.002 | 0.359 | −1.023 | 0.190–0.679 |
| GPER (low vs high) | <0.001 | 0.259 | 0.142–0.473 | 0.025 | 0.528 | −0.639 | 0.301–0.924 |
| Ezrin (low vs high) | <0.001 | 0.266 | 0.147–0.483 | 0.073 | 0.595 | −0.519 | 0.337–1.336 |
| Relapse event | |||||||
| Age | 0.197 | 0.977 | 0.943–1.012 | ||||
| Site (left vs right) | 0.808 | 1.094 | 0.530–2.258 | ||||
| Nuclear grade (G2 vs G3) | 0.049 | 0.230 | 0.053–0.994 | 0.050 | 0.239 | −1.433 | 0.057–1.001 |
| Tumor size | 0.950 | 1.007 | 0.881–1.250 | ||||
| LNM (no vs yes) | 0.005 | 0.336 | 0.158–0.716 | 0.209 | 0.569 | −0.564 | 0.236–1.372 |
| TNM (I/II vs III) | <0.001 | 0.235 | 0.111–0.498 | 0.023 | 0.368 | −0.998 | 0.156–0.871 |
| GPER (low vs high) | <0.001 | 0.229 | 0.108–0.485 | 0.004 | 0.329 | −1.113 | 0.153–0.704 |
| Ezrin (low vs high) | 0.019 | 0.414 | 0.199–0.863 | 0.752 | 0.884 | −0.124 | 0.410–1.904 |
| Distant event | |||||||
| Age | 0.301 | 0.985 | 0.957–1.014 | ||||
| Site (left vs right) | 0.529 | 0.823 | 0.448–1.511 | ||||
| Nuclear grade (G2 vs G3) | 0.010 | 0.201 | 0.060–0.676 | 0.005 | 0.184 | −1.695 | 0.056–0.602 |
| Tumor size | 0.075 | 1.165 | 0.985–1.379 | ||||
| LNM (no vs yes) | <0.001 | 0.310 | 0.165–0.585 | 0.070 | 0.525 | −0.644 | 0.262–1.053 |
| TNM (I/II vs III) | <0.001 | 0.174 | 0.090–0.334 | 0.022 | 0.449 | −0.801 | 0.227–0.889 |
| GPER (low vs high) | <0.001 | 0.124 | 0.063–0.242 | 0.001 | 0.346 | −1.061 | 0.182–0.658 |
| Ezrin (low vs high) | <0.001 | 0.108 | 0.054–0.214 | 0.001 | 0.320 | −1.139 | 0.162–0.631 |
*Logistic regressive model; **Cox regression model.
CI, confidence interval; HR, hazard ratio; LNM, lymph node metastasis; OR, odds ratio.
This work is licensed under a